EUVIMEDEUVIMED entdecken
Crossref

Effects of Low-Dose Atorvastatin on Hypoxic Response in Statin-Sensitive and Statin-Resistant Cancer Cells

Akihiro Sugiura, Tomoko Warita, Jiro Tashiro, Takuro Ishikawa, Katsuhiko Warita

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b25-00258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Akihiro Sugiura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Basic Veterinary Science, Joint Graduate School of Veterinary Sciences, Tottori University, 4-101 Koyama-cho, Minami, Tottori 680-8553, J…. Hauptthemen laut MEDLINE: Atorvastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Carcinoma, Non-Small-Cell Lung, Antineoplastic Agents. Die Arbeit nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins were initially developed as lipid-lowering agents to reduce the risk of cardiovascular and cerebrovascular diseases. Recently, their anti-tumor effects have gained attention in the context of drug repositioning. However, most in vitro studies have been conducted under normoxic conditions, and limited research has examined their effects under hypoxia. Since hypoxia plays a crucial role in the tumor microenvironment by promoting cancer cell proliferation, epithelial-mesenchymal transition, invasion, metastasis, and drug resistance, evaluating the anti-tumor effects of statins under hypoxic conditions is essential. Additionally, previous in vitro studies have used statin concentrations substantially higher than those observed in the serum during hyperlipidemia treatment, raising concerns about their clinical applicability as anti-tumor agents. Here, we demonstrate that a clinically relevant concentration of atorvastatin (0.1 μM) inhibits the migration and invasion of the statin-sensitive non-small cell lung cancer (NSCLC) cell line HOP-92 under hypoxic conditions, without inducing drug resistance. Furthermore, atorvastatin (0.1-1 μM) reduced the expression of hypoxia-inducible factor-1α (HIF-1α) in the statin-resistant NSCLC cell line NCI-H322M, even though it did not inhibit cell proliferation. Since cancer cell migration and invasion are key processes in distant metastasis, and HIF-1α is a critical transcription factor that regulates metastasis, these findings suggest that statins could be repurposed as anti-metastatic agents for NSCLC, particularly under hypoxic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtorvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsCarcinoma, Non-Small-Cell LungAntineoplastic AgentsLung NeoplasmsHumansCell Line, TumorDrug Resistance, NeoplasmCell MovementHypoxia-Inducible Factor 1, alpha SubunitCell ProliferationCell Hypoxia

Stichwörter der Autor:innen

angiogenesiscancerhypoxiahypoxia-inducible factor-1αmetastasisstatin

Substanzen

AtorvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsHypoxia-Inducible Factor 1, alpha SubunitAntineoplastic AgentsHIF1A protein, human

Autor:innen und Institutionen

  • Division of Basic Veterinary Science, Joint Graduate School of Veterinary Sciences, Tottori University, 4-101 Koyama-cho, Minami, Tottori 680-8553, Japan.
  • Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, 1 Gakuen Uegahara, Sanda, Hyogo 669-1330, Japan.

Zitieren

APA

Sugiura, A., Warita, T., Tashiro, J., Ishikawa, T., & Warita, K. (2025). Effects of Low-Dose Atorvastatin on Hypoxic Response in Statin-Sensitive and Statin-Resistant Cancer Cells. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00258

Vancouver

Sugiura A, Warita T, Tashiro J, Ishikawa T, Warita K. Effects of Low-Dose Atorvastatin on Hypoxic Response in Statin-Sensitive and Statin-Resistant Cancer Cells. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00258

BibTeX
@article{Sugiura2025,
  author = {Sugiura, Akihiro and Warita, Tomoko and Tashiro, Jiro and Ishikawa, Takuro and Warita, Katsuhiko},
  title = {Effects of Low-Dose Atorvastatin on Hypoxic Response in Statin-Sensitive and Statin-Resistant Cancer Cells},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b25-00258}
}
Kostenlos starten →